Development Partners International (DPI) has signed a $190 million agreement for a minority stake in Alameda Healthcare, the largest healthcare investment in Egypt, aimed at expanding the group's operations and improving healthcare access.
Information on the Target
Alameda Healthcare, established in 1999, stands as Egypt’s premier private healthcare group and the country's largest hospital operator, boasting more than 1,000 beds. Renowned for its Centers of Excellence, Alameda specializes in sophisticated medical practices, delivering high-quality, patient-centric healthcare services. Notably, its hospitals are accredited by the Joint Commission International (JCI), setting the gold standard for hospital quality globally. Among the five JCI-accredited hospitals in Egypt's private sector, Alameda comprises four, positioning itself as the only private healthcare group in Egypt with comprehensive JCI accreditation across all facilities.
The Group offers an extensive array of healthcare services, which encompass two internationally acknowledged tertiary care hospital brands—As-Salam International and Dar Al Fouad—along with seven polyclinics scattered throughout Egypt. Its specialized services extend to facilities such as the Elixir Gastro and Liver Care Center, the German Rehabilitation Center, and Tabibi 24/7, a home-based family healthcare service. Additionally, Alameda operates in-house diagnostic centers, medical laboratories, and pharmacies, establishing a robust healthcare network across the region.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Egypt
Egypt's healthcare sector has been undergoing substantial transformation, largely driven by increasing demand for quality health services and the prevailing need for modern hospitals equipped with advanced technologies. The Egyptian government has made it a priority
Similar Deals
Development Partner International and Amethis → Marcyrl Pharmaceutical Industries
2023
SPE Capital Partners → Future Pharmaceutical Industries
2023
Development Partners International, Amethis → Marcyrl Pharmaceutical Industries
2023
B Healthcare Investments → The Egyptian IVF Center
2021
Growth Lending → A & R Care Limited
2025
New Mountain Capital → Smarter Technologies
2025
Development Partners International
invested in
Alameda Healthcare
in 2025
in a Growth Equity & Expansion Capital deal
Disclosed details
Transaction Size: $190M